FIELD: chemistry.
SUBSTANCE: invention refers to mononuclear cationic dinitrosyl iron complexes of general formula [Fe(SR)2(NO)2]n +X-, wherein n = 1-4, X = acid residue; R represents thiocarbamide, its derivatives. There are also presented a method for producing the iron complexes and a nitrogen monoxide donor.
EFFECT: invention enables producing new dinitrosyl iron complexes, which are applicable as effective nitrogen monoxide donors.
3 cl, 2 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MONONECLEAR DINITROSYL FERRIC COMPLEXES, METHOD FOR PREPARING MONONECLEAR DINITROSYL FERRIC COMPLEXES, NITROGEN MONOXIDE DONOR, USING MONONECLEAR DINITROSYL FERRIC COMPLEXES AS ANTI-TUMOUR DRUG | 2011 |
|
RU2494104C2 |
| METHOD OF DETECTING NITROSO-COMPOUNDS AND NITRITE IN BIOLOGICAL OBJECTS | 2008 |
|
RU2395096C2 |
| USE OF NITROSYL IRON COMPLEX WITH N,N-DIETHYLTHIOUREA AS NEW NO-DONOR ANTICANCER AGENT | 2016 |
|
RU2687269C2 |
| AGENT WITH ANTIVIRAL ACTIVITY AGAINST SARS-COV-2 AND METHOD OF USING THE SAME | 2022 |
|
RU2797619C1 |
| SUPRAMOLECULAR ASSEMBLIES OF DINITROSYL IRON COMPLEXES, METHOD OF THEIR PREPARATION, NITROGEN MONOXIDE DONORS, PHOSPHODIESTERASE INHIBITORS, USE OF SUPRAMOLECULAR ASSEMBLIES OF DINITROSYL IRON COMPLEXES AS ANTI-INFLAMMATORY MEDICINAL PRODUCTS | 2023 |
|
RU2814108C1 |
| USE OF BINUCLEAR SULPHUR-NITROSYL CATIONIC IRON COMPLEX AS VASODILATATOR | 2010 |
|
RU2460531C2 |
| HYDROGEL COMPOSITION FOR TREATING INVESTING TISSUE DEFECTS BY PHOTODYNAMIC THERAPY | 2020 |
|
RU2730850C1 |
| APPLICATION OF BINUCLEAR SULPHUR-NITROSYL COMPLEX OF ANION TYPE IRON AS VASODEPRESSOR MEDICATION | 2010 |
|
RU2437667C1 |
| REVERSIBLE THERMOCHEMICAL INDICATOR | 2012 |
|
RU2499800C1 |
| AGENT AGAINST MYOCARDIAL HYPOXIA | 2013 |
|
RU2522953C1 |
